Ten years later, Lilly’s long-term Alzheimer’s trial of solanezumab has
Ten years later, Lilly's long-term Alzheimer's trial of solanezumab has definitively failed Endpoints NewsEli Lilly Alzheimer's treatment solanezumab failed to slow disease progression CNBCLilly's 10-year bet on treating Alzheimer's…